| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $2.13 (Beat by $0.04) |
| EPS GAAP Actual | $2.13 (Beat by $0.04) |
| Revenue Actual | $4.082B |
| Revenue Surprise | Beat by $4082M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.5253 |
| EPS GAAP Estimate | $2.5253 |
| Revenue Estimate | $4.890864513B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 9.7 | 9.92 | 9.394 | 9.88354 | 1 |
| Dec 2028 | 10.26 | 9.38 | 10.06539 | 10.47518 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.01 | -0.73163 | 4.082B | -12.08% | -990.79M |
| FQ2 2025 (Jun 2025) | 1.98 | -0.82716 | 4.195B | -14.28% | -977.98M |
| FQ1 2025 (Mar 2025) | 1.64 | 1.64 | 3.684B | -17.02% | 3684M |
| FQ4 2024 (Dec 2024) | -1.2 | -1.2 | 2.165B | -100.92% | 2165M |
| FQ3 2024 (Sep 2024) | 2.01 | 2.01 | 4.575B | -1.51% | 4575M |
| FQ2 2024 (Jun 2024) | 2.25 | 2.25 | 4.794B | -1.63% | 4794M |
| FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 4.311B | -1.6% | 4311M |
| FQ3 2023 (Sep 2023) | 1.8 | 1.8 | 4.644B | 100% | 4644M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.5253
Consensus Revenue Estimates
4.890864513B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.1951 | -- | 2.12164 | 2.30766 | 4 |
| FQ3 2027 (Sep 2027) | 2.73046 | -- | 2.63909 | 2.87048 | 3 |
| FQ2 2027 (Jun 2027) | 3.00849 | -- | 2.90781 | 3.16276 | 4 |
| FQ1 2027 (Mar 2027) | 2.20915 | -- | 2.13522 | 2.32243 | 3 |
| FQ4 2026 (Oct 2026) | 2.74152 | -- | 2.69919 | 2.78381 | 9 |
| FQ3 2026 (Jul 2026) | 3.04835 | 34.06 | 3.00128 | 3.09537 | 9 |
| FQ2 2026 (Jun 2026) | 3.1116 | 36.37 | 3.05368 | 3.15159 | 9 |
| FQ1 2026 (Mar 2026) | 2.3702 | 30.81 | 2.32608 | 2.40066 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.12B | -- | 4.01B | 4.28B | 5 |
| FQ3 2027 (Sep 2027) | 4.33B | -- | 4.21B | 4.5B | 4 |
| FQ2 2027 (Jun 2027) | 4.47B | -- | 4.36B | 4.65B | 5 |
| FQ1 2027 (Mar 2027) | 3.99B | -- | 3.88B | 4.14B | 4 |
| FQ4 2026 (Oct 2026) | 5.1B | -- | 5.04B | 5.16B | 8 |
| FQ3 2026 (Jul 2026) | 5.3B | 22.98 | 5.24B | 5.36B | 5 |
| FQ2 2026 (Jun 2026) | 5.42B | 22.58 | 5.34B | 5.47B | 5 |
| FQ1 2026 (Mar 2026) | 4.81B | 23.47 | 4.74B | 4.86B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.74163 | 2.01 | -0.73163 | -36.4% |
| FQ2 2025 (Jun 2025) | 2.80716 | 1.98 | -0.82716 | -41.78% |
| FQ1 2025 (Mar 2025) | 1.64 | 1.64 | 100% | |
| FQ4 2024 (Dec 2024) | -1.2 | -1.2 | 100% | |
| FQ3 2024 (Sep 2024) | 2.01 | 2.01 | 100% | |
| FQ2 2024 (Jun 2024) | 2.25 | 2.25 | 100% | |
| FQ1 2024 (Mar 2024) | 1.7 | 1.7 | 100% | |
| FQ3 2023 (Sep 2023) | 1.8 | 1.8 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $5.07B | $4.08B | $-990.79M | -24.27% |
| FQ2 2025 (Jun 2025) | $5.17B | $4.2B | $-977.98M | -23.31% |
| FQ1 2025 (Mar 2025) | $0B | $3.68B | $3684M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.17B | $2165M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.58B | $4575M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.79B | $4794M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $4.31B | $4311M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $4.64B | $4644M | 100% |